On the afternoon of June 15, 2018, the company held the 2017 Annual Shareholders' Meeting in the conference room on the third floor of Howard Johnson Zhongjin Hotel in Shaoxing. Chairman Li Chunbo chaired the meeting, and the company's shareholders, shareholder representatives, and institutional investors attended the meeting. The company's directors, supervisors and some senior executives attended the meeting.
The meeting reviewed and approved the "2017 Annual Report of the Board of Directors", "The 2017 Annual Report of the Board of Supervisors", "The 2017 Financial Statements of the Company", "The 2017 Annual Profit Distribution Plan", "The 2017 Annual Report of the Company" and its summary , "Proposal on Renewing the Appointment of Accounting Firms and Paying Remuneration", "Proposal on Adjusting the Allowance of Independent Directors", "Proposal on Modifying Certain Terms of the" Articles of Association "", the meeting elected Mr. Li Chunbo, Mr. Li Junxi, Mr. Wang Wei, Mr. Lu Chunlei, Mr. Li Nanxing, Mr. Zhu Jinlin, and Mr. Ma Wenxin are directors of the eighth session of the board of directors of the company. Mr. Peng Shiqi, Mr. Huang Dongliang, Mr. Zhu Jianwei, and Mr. Chen Naiwei are independent directors of the eighth session of the board of directors. Mr. Zhang Bin, Cao Yong Mr. He Yimin is the supervisor of the eighth session of the Supervisory Committee of the Company.
After the shareholders' meeting, the eighth board meeting of the company was held in the conference room on the fourth floor of CICC Howard. Mr. Li Chunbo chaired the meeting and the newly elected company director attended the meeting. The meeting unanimously elected Mr. Li Chunbo as the chairman of the eighth board of directors and Mr. Li Junxi as the vice chairman.
Nominated by the chairman, the meeting agreed to appoint Mr. Lu Chunlei as the company's president; Mr. Ye Weidong was the company's board secretary. Upon the nomination of the president, the meeting agreed to hire Mr. Li Nanxing as the company's executive vice president; Mr. Zhu Jinlin as the company's vice president in charge of quality; Mr. Ma Wenxin as the company's vice president in charge of safety and environmental protection; Mr. Zhao Junxing as the company's senior management and in charge of the development of export preparations (Chief Scientist); Mr. Zhang Dingfeng is a senior manager of the company and is in charge of Zhejiang Changhai Pharmaceutical Co., Ltd .; Mr. Yu Huanming is a senior manager of the company and is responsible for the marketing of domestic pharmaceutical preparations; Mr. Lu Xufeng is a senior manager of the company and is in charge of the Xinchang Pharmaceutical Factory; Mr. Wang Hongwei She is a senior manager of the company and is in charge of Changhai Biological Branch; Ms. Zhang Peihong is the company's chief financial officer. Nominated by the secretary of the board of directors, the meeting agreed to appoint Ms. Wu Mengmeng as a securities affairs representative.
Immediately after the board meeting, the eighth session of the Supervisory Board was convened. Mr. Zhang Bin was unanimously elected as the chairman of the eighth session of the Supervisory Board of the Company.